• Home
  • Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.

Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.

Author List
Cooperberg MR, Lin DW, Morgan TM, Chapin BF, Chen RC, Eggener SE
Publication
The Journal of urology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/245061670
Publication Year
2021
PubMed ID
34775795
Publication Title
Cooperberg MR, Lin DW, Morgan TM, Chapin BF, Chen RC, Eggener SE. Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer. J Urol. 2022 02; 207(2):262-264.